| 注册
首页|期刊导航|中医学报|中医药调控TLR4信号通路防治糖尿病肾病研究进展

中医药调控TLR4信号通路防治糖尿病肾病研究进展

高亚丽 段玉红 王慧霞 董佩

中医学报2024,Vol.39Issue(8):1695-1700,6.
中医学报2024,Vol.39Issue(8):1695-1700,6.DOI:10.16368/j.issn.1674-8999.2024.08.278

中医药调控TLR4信号通路防治糖尿病肾病研究进展

Research Progress of TCM in Prevention and Treatment of Diabetic Nephropathy by Regulating TLR4 Signaling Pathway

高亚丽 1段玉红 2王慧霞 1董佩1

作者信息

  • 1. 陕西中医药大学,陕西 咸阳 712000
  • 2. 陕西中医药大学附属医院,陕西 咸阳 712000
  • 折叠

摘要

Abstract

The TLR4 signaling pathway is closely related to the pathogenesis of diabetic kidney disease(DKD).TCM has achieved good clinical efficacy in the prevention and treatment of DKD with some advantages such as multiple targets,effects,and components.TCM can inhibit the kidney inflammation,reducing oxidative stress,improve renal fibrosis and decrease cell apoptosis by regulating TLR4 sig-naling pathway,which has become an important target for the prevention and treatment of DKD with TCM.However,at present,the re-search related to the prevention and treatment of DKD by traditional Chinese medicine is still mainly based on basic experiments,and there is a lack of high-quality large-sample clinical trial verification.The existing research are mostly focused on single signaling pathway,and the molecular mechanism has not been clarified.From this prospect,it is necessary to further explore the connection and intersection of multiple pathways such as TLR4 to clarify mechanism of the multi-target and multi-pathway,as well as the active com-ponents of TCM and their mechanism by using network pharmacology and multi-omics joint analysis technology,so as to provide new i-deas for the prevention and treatment of DKD with TCM.

关键词

糖尿病肾病/TLR4信号通路/中医药

Key words

diabetic kidney disease/TLR4 signaling pathway/traditional Chinese medicine

分类

医药卫生

引用本文复制引用

高亚丽,段玉红,王慧霞,董佩..中医药调控TLR4信号通路防治糖尿病肾病研究进展[J].中医学报,2024,39(8):1695-1700,6.

基金项目

陕西省中医药管理局科研计划项目(2019-GJ-QT002) (2019-GJ-QT002)

陕西省自然科学基础研究计划项目(2022JM-494) (2022JM-494)

中医学报

OACSTPCD

1674-8999

访问量7
|
下载量0
段落导航相关论文